BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

947 related articles for article (PubMed ID: 25046161)

  • 1. Cell death and cell death responses in liver disease: mechanisms and clinical relevance.
    Luedde T; Kaplowitz N; Schwabe RF
    Gastroenterology; 2014 Oct; 147(4):765-783.e4. PubMed ID: 25046161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cell Death in Liver Diseases: A Review.
    Shojaie L; Iorga A; Dara L
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33353156
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis.
    Afonso MB; Rodrigues PM; Carvalho T; Caridade M; Borralho P; Cortez-Pinto H; Castro RE; Rodrigues CM
    Clin Sci (Lond); 2015 Oct; 129(8):721-39. PubMed ID: 26201023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lytic cell death in metabolic liver disease.
    Gautheron J; Gores GJ; Rodrigues CMP
    J Hepatol; 2020 Aug; 73(2):394-408. PubMed ID: 32298766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and necroptosis in the liver: a matter of life and death.
    Schwabe RF; Luedde T
    Nat Rev Gastroenterol Hepatol; 2018 Dec; 15(12):738-752. PubMed ID: 30250076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cell death mechanisms in non-alcoholic steatohepatitis].
    Magusto J; Majdi A; Gautheron J
    Biol Aujourdhui; 2020; 214(1-2):1-13. PubMed ID: 32773025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptosis and non-alcoholic fatty liver diseases.
    Kanda T; Matsuoka S; Yamazaki M; Shibata T; Nirei K; Takahashi H; Kaneko T; Fujisawa M; Higuchi T; Nakamura H; Matsumoto N; Yamagami H; Ogawa M; Imazu H; Kuroda K; Moriyama M
    World J Gastroenterol; 2018 Jul; 24(25):2661-2672. PubMed ID: 29991872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptor interacting protein 3 protects mice from high-fat diet-induced liver injury.
    Roychowdhury S; McCullough RL; Sanz-Garcia C; Saikia P; Alkhouri N; Matloob A; Pollard KA; McMullen MR; Croniger CM; Nagy LE
    Hepatology; 2016 Nov; 64(5):1518-1533. PubMed ID: 27301788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Necroptosis in Ligand-Mediated and Hypoxia-Induced Injury of Hepatocytes Using a Novel Optic Probe-Detecting Receptor-Interacting Protein (RIP)1/RIP3 Binding.
    Haga S; Kanno A; Ozawa T; Morita N; Asano M; Ozaki M
    Oncol Res; 2018 Apr; 26(3):503-513. PubMed ID: 28770700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decoding cell death signals in liver inflammation.
    Brenner C; Galluzzi L; Kepp O; Kroemer G
    J Hepatol; 2013 Sep; 59(3):583-94. PubMed ID: 23567086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomarkers of liver cell death.
    Eguchi A; Wree A; Feldstein AE
    J Hepatol; 2014 May; 60(5):1063-74. PubMed ID: 24412608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic ferroptosis plays an important role as the trigger for initiating inflammation in nonalcoholic steatohepatitis.
    Tsurusaki S; Tsuchiya Y; Koumura T; Nakasone M; Sakamoto T; Matsuoka M; Imai H; Yuet-Yin Kok C; Okochi H; Nakano H; Miyajima A; Tanaka M
    Cell Death Dis; 2019 Jun; 10(6):449. PubMed ID: 31209199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necroptotic Cell Death in Liver Transplantation and Underlying Diseases: Mechanisms and Clinical Perspective.
    Shi S; Verstegen MMA; Mezzanotte L; de Jonge J; Löwik CWGM; van der Laan LJW
    Liver Transpl; 2019 Jul; 25(7):1091-1104. PubMed ID: 31077562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Divergent effects of RIP1 or RIP3 blockade in murine models of acute liver injury.
    Deutsch M; Graffeo CS; Rokosh R; Pansari M; Ochi A; Levie EM; Van Heerden E; Tippens DM; Greco S; Barilla R; Tomkötter L; Zambirinis CP; Avanzi N; Gulati R; Pachter HL; Torres-Hernandez A; Eisenthal A; Daley D; Miller G
    Cell Death Dis; 2015 May; 6(5):e1759. PubMed ID: 25950489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Necroptosis: an emerging type of cell death in liver diseases.
    Saeed WK; Jun DW
    World J Gastroenterol; 2014 Sep; 20(35):12526-32. PubMed ID: 25253954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of necroptosis in human and experimental cholestasis.
    Afonso MB; Rodrigues PM; Simão AL; Ofengeim D; Carvalho T; Amaral JD; Gaspar MM; Cortez-Pinto H; Castro RE; Yuan J; Rodrigues CM
    Cell Death Dis; 2016 Sep; 7(9):e2390. PubMed ID: 27685634
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Receptor Interacting Protein Kinases in the Liver.
    Dara L
    Semin Liver Dis; 2018 Feb; 38(1):73-86. PubMed ID: 29471568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Novel factors playing a role in the pathomechanism of diffuse liver diseases: apoptosis and hepatic stem cells].
    Schaff Z; Nagy P
    Orv Hetil; 2004 Aug; 145(35):1787-93. PubMed ID: 15493221
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactive oxygen species mediate human hepatocyte injury during hypoxia/reoxygenation.
    Bhogal RH; Curbishley SM; Weston CJ; Adams DH; Afford SC
    Liver Transpl; 2010 Nov; 16(11):1303-13. PubMed ID: 21031546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes.
    Hirsova P; Ibrahim SH; Krishnan A; Verma VK; Bronk SF; Werneburg NW; Charlton MR; Shah VH; Malhi H; Gores GJ
    Gastroenterology; 2016 Apr; 150(4):956-67. PubMed ID: 26764184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.